X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 12c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.26), $0.12 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance